Corporate digest


GIC has joined a consortium of institutional investors, led by Hillhouse Capital Group, to invest around US$418 million through a private placement in Nasdaq-listed I-Mab, a clinical stage biopharmaceutical company.

I-Mab is committed to the discovery, development and commercialisation of novel biologics,...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to